You are here

Article info

Article menu
XML
Basic tumor immunology
Original research
LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

Authors

  • Rongmu Xia Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University; School of Clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, ChinaSchool of Medicine, Xiamen University, Xiamen 361102, Fujian Province, China PubMed articlesGoogle scholar articles
  • Guojun Geng Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic tumor diagnosis and treatment, Institute of lung cancer, The First Affiliated Hospital of Xiamen University; School of clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Xiuyi Yu Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic tumor diagnosis and treatment, Institute of lung cancer, The First Affiliated Hospital of Xiamen University; School of clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Zhong Xu Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic tumor diagnosis and treatment, Institute of lung cancer, The First Affiliated Hospital of Xiamen University; School of clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Jing Guo Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University; School of Clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Hongming Liu Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic tumor diagnosis and treatment, Institute of lung cancer, The First Affiliated Hospital of Xiamen University; School of clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Ning Li Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic tumor diagnosis and treatment, Institute of lung cancer, The First Affiliated Hospital of Xiamen University; School of clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Ziyan Li Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University; School of Clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Yingli Li Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University; School of Clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Xiaofang Dai Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China PubMed articlesGoogle scholar articles
  • Qicong Luo Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University; School of Clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Jie Jiang Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic tumor diagnosis and treatment, Institute of lung cancer, The First Affiliated Hospital of Xiamen University; School of clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  • Yanjun Mi Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University; School of Clinical Medicine, Fujian Medical University, Xiamen 361003, Fujian Province, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Yanjun Mi; Miyj77{at}xmu.edu.cn; Professor Jie Jiang; Jiejiangfy{at}163.com; Professor Qicong Luo; rokey526{at}163.com; Professor Xiaofang Dai; 13707127709{at}163.com
View Full Text

Citation

Xia R, Geng G, Yu X, et al
LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs
Journal for ImmunoTherapy of Cancer 2021;9:e002746. doi: 10.1136/jitc-2021-002746

Publication history

  • Accepted July 26, 2021
  • First published August 25, 2021.
Online issue publication 
November 02, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.